Vycor Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VYCO research report →
About the company
Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units.
- CEO
- Peter C. Zachariou
- IPO
- 2013
- Employees
- 7
- HQ
- Boca Raton, FL, US
Price Chart
- Market Cap
- $2.10M
- P/E
- -157.50
- P/S
- 1.12
- P/B
- -0.50
- EV/EBITDA
- 20.81
- Div Yield
- 0.00%
- Gross Margin
- 82.93%
- Op Margin
- 4.91%
- Net Margin
- -0.73%
- ROE
- 0.34%
- ROIC
- -2.85%
- Revenue
- $1.86M · 17.24%
- Net Income
- $-72,426 · 32.44%
- EPS
- $-0.01 · -260.61%
- Op Income
- $33.90K
- FCF YoY
- -133.44%
- 52W High
- $0.20
- 52W Low
- $0.03
- 50D MA
- $0.07
- 200D MA
- $0.12
- Beta
- -0.53
- Avg Volume
- 6.78K
Get TickerSpark's AI analysis on VYCO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 30, 22 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Jun 30, 22 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Mar 31, 22 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Sep 30, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Sep 30, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Jun 30, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Mar 31, 21 | Rush Lowell | other | 33,333 |
| Mar 31, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Apr 1, 21 | GIRGENTI STEVEN | other | 33.333 |
| Jan 1, 21 | GIRGENTI STEVEN | other | 33.333 |
Our VYCO coverage
Recent articles, reports, and earnings notes.
No research on VYCO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VYCO report →Similar companies
Peers in the same neighborhood.